Previous Article | Next Article ![]()
Infect Immun, April 1998, p. 1439-1444, Vol. 66, No. 4
Neose Technologies, Inc., Horsham,
Pennsylvania 19044
Received 6 October 1997/Returned for modification 18 November
1997/Accepted 12 January 1998
To study carbohydrate-mediated adherence of Streptococcus
pneumoniae to the human airway, we measured binding of live
S. pneumoniae organisms to a cultured cell line derived
from the lining of the conjunctiva and to primary monolayers of human
bronchial epithelial cells in the presence and absence of
oligosaccharide inhibitors. Both encapsulated and nonencapsulated
strains of S. pneumoniae grown to mid-logarithmic phase
in suspension culture adhered to cultured primary respiratory
epithelial cells and the conjunctival cell line.
Adherence of nine clinically prevalent S. pneumoniae capsular types studied was inhibited preferentially by
sialylated oligosaccharides that terminate with the disaccharide
NeuAc
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Adherence of Streptococcus pneumoniae to Respiratory
Epithelial Cells Is Inhibited by Sialylated
Oligosaccharides
2-3(or 6)Gal
1. Adherence of some strains also was weakly
inhibited by oligosaccharides that terminate with lactosamine
(Gal
1-4GlcNAc
1). When sialylated oligosaccharides were covalently
coupled to human serum albumin at a density of approximately 20 oligosaccharides per molecule of protein, the molar inhibitory potency
of the oligosaccharide inhibitor was enhanced 500-fold.
The above-mentioned experiments reveal a previously unreported
dependence upon sialylated carbohydrate ligands for
adherence of S. pneumoniae to human upper airway epithelial cells. Enhanced inhibitory potencies of polyvalent over
monovalent forms of oligosaccharide inhibitors of adherence suggest
that the putative adhesin(s) that recognizes the structure
NeuAc
2-3(or 6)Gal
1 is arranged on the bacterial
surface in such a manner that it may be cross-linked by
oligosaccharides covalently linked to human serum albumin.
*
Corresponding author. Mailing address: Neose
Technologies, 102 Witmer Rd., Horsham, PA 19044. Phone: (215) 773-1756. Fax: (215) 441-5896. E-mail: rbarthel{at}neose.com.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|